Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. - Wikidata - awgldk - TriplyDB

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.

http://www.wikidata.org/entity/Q37315448

about

Rotenone, paraquat, and Parkinson's disease LC/MS analysis of cardiolipins in substantia nigra and plasma of rotenone-treated rats: implication for mitochondrial dysfunction in Parkinson's disease LC/MS characterization of rotenone induced cardiolipin oxidation in human lymphocytes: implications for mitochondrial dysfunction associated with Parkinson's disease LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1 Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease Parkinson's Disease: The Mitochondria-Iron Link Ion Channels and Oxidative Stress as a Potential Link for the Diagnosis or Treatment of Liver Diseases Oncostatic-Cytoprotective Effect of Melatonin and Other Bioactive Molecules: A Common Target in Mitochondrial Respiration Melatonin and Other Tryptophan Metabolites Produced by Yeasts: Implications in Cardiovascular and Neurodegenerative Diseases Redox Modulations, Antioxidants, and Neuropsychiatric Disorders The Emerging Role of Disturbed CoQ Metabolism in Nonalcoholic Fatty Liver Disease Development and Progression Old Things New View: Ascorbic Acid Protects the Brain in Neurodegenerative Disorders Mitophagy programs: mechanisms and physiological implications of mitochondrial targeting by autophagy Mitochondria: A Therapeutic Target for Parkinson's Disease?Overview of Nrf2 as Therapeutic Target in Epilepsy Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases Mitochondrial quality control: decommissioning power plants in neurodegenerative diseases Upstream deregulation of calcium signaling in Parkinson's disease A conserved role for p48 homologs in protecting dopaminergic neurons from oxidative stress cAMP/PKA signaling balances respiratory activity with mitochondria dependent apoptosis via transcriptional regulation.Dynamics of Human Mitochondrial Complex I Assembly: Implications for Neurodegenerative Diseases Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease Lipid pathway alterations in Parkinson's disease primary visual cortex Genetic modification of the association of paraquat and Parkinson's disease Identification and characterization of a leucine-rich repeat kinase 2 (LRRK2) consensus phosphorylation motif A water soluble CoQ10 formulation improves intracellular distribution and promotes mitochondrial respiration in cultured cells Preclinical Metabolism, Pharmacokinetics and In Vivo Analysis of New Blood-Brain-Barrier Penetrant Fingolimod Analogues: FTY720-C2 and FTY720-Mitoxy Dopamine neuron stimulating actions of a GDNF propeptide Rotenone-dependent changes of anterograde motor protein expression and mitochondrial mobility in brain areas related to neurodegenerative diseases Parkinson's disease brain mitochondria have impaired respirasome assembly, age-related increases in distribution of oxidative damage to mtDNA and no differences in heteroplasmic mtDNA mutation abundance L-type calcium channel blockers and Parkinson disease in Denmark.Hyperexcitable substantia nigra dopamine neurons in PINK1- and HtrA2/Omi-deficient mice.A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1.Fine mapping of gene regions regulating neurodegeneration Memory-enhancing activities of the aqueous extract of Albizia adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson's disease Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson's Disease VPS35 regulates parkin substrate AIMP2 toxicity by facilitating lysosomal clearance of AIMP2.

P2860

Q22241595-9D41F4B7-3ABB-462A-B082-FD62D683A38F Q23923990-D74ED49C-6299-42E0-8E81-E3537D9EAA8B Q23924133-1E795CD3-63DE-4268-A0FC-855BC8A4B851 Q24301357-85ECC14E-0C0D-46CC-A62B-CEA5CC632828 Q24337079-DE36041B-7CA4-4D58-966C-2E2041BB8C9E Q24597726-AB013C0B-9C71-4CEC-894B-170CCA5FD0CF Q26746899-FB19E923-D7BC-427E-9E99-2AEE34A3B0B2 Q26765808-7172B2A5-D603-4E08-93BD-0EB13D5C57D1 Q26766876-C6B53B15-E8B5-422D-B068-557D9A5CA39F Q26772733-975529BD-A0EA-4794-BF8E-BC91A068228F Q26774067-4EB02F99-0D66-4A35-A598-432600FFD07A Q26775025-1FA37ADE-57F2-4263-A9FD-0B637532D498 Q26775096-ABA3CAA8-0461-4007-A501-179D42BC0843 Q26776469-DE6CAFE3-E727-4D96-99EF-2E1B412F7303 Q26784216-28D8C664-A337-4226-B304-DB0CF2BF733A Q26799344-7486248A-5EBF-4F77-8081-9C91320E43E3 Q26859141-C738E5C8-1545-4080-B090-8319DDB9CB5B Q27009213-26B6B3C8-1A02-4C96-8E76-168E18EFB611 Q27026384-65E7B061-5EB8-4C07-A29B-A41A4BFCFA62 Q27312249-0604A6DD-3912-499F-B410-AA9418B42615 Q27939781-775ABC23-D94F-4CF4-9B48-8A3387AE1DB0 Q28069775-09F1B8B2-BD07-4217-8072-82B73EA2B392 Q28074143-0D8EE669-3F88-41D1-A637-6365F24408C1 Q28084254-723B7A3E-B46D-4260-8696-710D96C4042A Q28280353-F3DA59CF-F89B-4B1C-B3A7-9091BDED93AE Q28386548-6DBB7110-8E2B-47E2-A4EB-EF24B8F315F9 Q28394396-8E5ECEE1-6CB1-48D1-83EB-B9936A4C55AC Q28475942-ABE00320-29F5-4F2F-A97E-20114116233E Q28481504-55B60AEB-264F-4635-8115-598FD58DF4D4 Q28553993-2BDE80DF-3C7A-4973-B670-2CAD541BF71A Q28748465-21FB4892-B5BC-4ACD-8205-069F828CFDC7 Q28854315-E74AF789-28A5-47D2-9D0A-F0DE54F4AE75 Q30438194-ECC298E2-8B84-4E77-8BC0-02DE6DA30537 Q30495902-0AA50435-94C5-477E-B590-349D5C19C91E Q30497725-ADFF216A-8CAB-49EF-A66B-4640D1C6C69D Q30573927-2F24F23C-FCA6-4299-89A0-947DD1CEDD69 Q33467388-4F7A3131-4D87-4356-8A3F-B430FF381A17 Q33606408-1907FA24-8DC6-4F4F-A98C-F63B98978C67 Q33749270-96BC516E-983E-4035-A270-09DCA2064FBF Q33815889-B8899DFA-1F83-4B25-ACCF-EA747388C095

P2860

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.

http://www.wikidata.org/entity/Q37315448

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.

@en

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.

@nl

type

label

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.

@en

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.

@nl

prefLabel

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.

@en

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.

@nl

P1433

Q37315448-DC712B62-C1D4-4233-97C1-33D5DA7FDCB0

P1476

Q37315448-A3A24A27-C414-43BA-8833-BA4630F69B8A

P2093

Q37315448-25B80F52-F372-420D-9E9E-5FBF09574E88

Q37315448-BFAC542F-B7CE-43C5-AACC-C6EE42230AC3

P2860

Q37315448-005B8929-FA42-4752-8CED-DB59F1256A02

Q37315448-00761F56-67A0-41C8-9D40-85B698D6421A

Q37315448-04916693-380C-4256-86A0-870DD6E0556D

Q37315448-04B6E0C6-A5F1-4DCB-B7C2-6557D51B7E8C

Q37315448-05FE0694-9531-4284-B3BB-29FC5E5B0736

Q37315448-0BD9FC65-5EA9-4348-8649-B1BC62C819D3

Q37315448-0EA0DACD-197D-4F87-8D11-016E9842128D

Q37315448-15CCE130-F4FE-47D1-8744-336E29311DCF

Q37315448-163B7BF5-6D59-480D-9FBE-C0011B6D8D25

Q37315448-18FF21C6-592D-459E-809E-2E3D0D419BEA

P304

Q37315448-3C7C61A5-37B6-4CB1-AE34-A69FBC65A165

P31

Q37315448-D3ACA7E9-F3F5-4382-A477-5BA54318C234

P356

Q37315448-EC5E94FC-3A7C-4F8D-888B-E76ED5392B0A

P433

Q37315448-4B704E1B-952A-416A-A0AD-B60D93B8FED6

P478

Q37315448-322532AB-79AF-4E92-933C-E1DA9DD172B5

P577

Q37315448-55B97041-6F57-4E14-BC53-759B7E3E5CB4

P5875

Q37315448-B8B3B3E9-F037-4D3B-943D-B736E286A00C

P698

Q37315448-017559BD-C1AE-40F2-95F7-0A14C7FCAA36

P921

Q37315448-6ED992CB-7BF1-4714-AD20-4D3BF9BC0755

Q37315448-87FE32F9-7A26-433C-9BB8-9DC82FABD825

Q37315448-E5D1A94C-9F36-4AEF-9A1D-47631CE97EF1

P356

P1433

Nature Clinical Practice Neurology

P1476

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.

@en

P2093

Claire Henchcliffe

http://www.w3.org/2001/XMLSchema#string

M Flint Beal

http://www.w3.org/2001/XMLSchema#string

P2860

DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity

Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.

Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition

Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis

DJ-1 has a role in antioxidative stress to prevent cell death

PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons

P304

600-609

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCPNEURO0924

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23446222

http://www.w3.org/2001/XMLSchema#string

P698

18978800

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease